Takeshi Ebara

Summary

Affiliation: Gunma University
Country: Japan

Publications

  1. ncbi Palliative re-irradiation for in-field recurrence after definitive radiotherapy in patients with primary lung cancer
    Takeshi Ebara
    Department of Radiation, Shizuoka General Hospital, Shizuoka
    Anticancer Res 27:531-4. 2007
  2. ncbi L-type amino-acid transporter 1 expression predicts the response to preoperative hyperthermo-chemoradiotherapy for advanced rectal cancer
    Takeshi Ebara
    Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
    Anticancer Res 30:4223-7. 2010
  3. ncbi Inoperable Pancoast tumors treated with hyperthermia-inclusive multimodality therapies
    Takeshi Ebara
    Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma 371 8511, Japan
    Lung Cancer 63:247-50. 2009
  4. ncbi Expression of hypoxia-inducible factor 1? predicts clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer
    Mariko Shioya
    Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma 371 8511, Japan
    J Radiat Res 52:821-7. 2011
  5. ncbi Phase I study of oral S-1 plus Cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer
    Kyoichi Kaira
    Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
    Int J Radiat Oncol Biol Phys 75:109-14. 2009
  6. ncbi Usefulness of intraluminal brachytherapy combined with external beam radiation therapy for submucosal esophageal cancer: long-term follow-up results
    Hitoshi Ishikawa
    Department of Radiation Oncology, Gunma University Graduate School of Medicine, 3 39 22 Showa machi, Maebashi, Gunma 371 8511, Japan
    Int J Radiat Oncol Biol Phys 76:452-9. 2010
  7. ncbi Interaction of radiation and pemetrexed on a human malignant mesothelioma cell line in vitro
    Daisaku Yoshida
    Department of Radiation Oncology, Gunma University, Graduate School of Medicine, 3 39 22, Showa machi, Maebashi, Gunma 371 8511, Japan
    Anticancer Res 31:2847-51. 2011
  8. ncbi Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: the relationship between dose-volume histogram parameters and the occurrence rate
    Masahiko Okamoto
    Department of Radiation Oncology, Gunma University Graduate School of Medicine, Gunma, Japan
    Int J Radiat Oncol Biol Phys 82:e211-7. 2012
  9. ncbi The benefit of small bowel and pelvic bone sparing in excluding common iliac lymph node region from conventional radiation fields in patients with uterine cervical cancer: a dosimetric study
    Takahiro Oike
    Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
    J Radiat Res 51:715-21. 2010
  10. ncbi Primary mediastinal synovial sarcoma: a report of 2 cases
    Kyoichi Kaira
    Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Gunma, Japan
    J Comput Assist Tomogr 32:238-41. 2008

Detail Information

Publications10

  1. ncbi Palliative re-irradiation for in-field recurrence after definitive radiotherapy in patients with primary lung cancer
    Takeshi Ebara
    Department of Radiation, Shizuoka General Hospital, Shizuoka
    Anticancer Res 27:531-4. 2007
    ..To evaluate the efficacy and toxicity of palliative re-irradiation for in-field recurrence of primary lung cancer after radiotherapy...
  2. ncbi L-type amino-acid transporter 1 expression predicts the response to preoperative hyperthermo-chemoradiotherapy for advanced rectal cancer
    Takeshi Ebara
    Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
    Anticancer Res 30:4223-7. 2010
    ..To evaluate whether expression of L-type amino acid transporter 1 (LAT1) in pretreatment rectal cancer biopsies is predictive of tumour response to neoadjuvant hyperthermo-chemoradiotherapy (HCRT)...
  3. ncbi Inoperable Pancoast tumors treated with hyperthermia-inclusive multimodality therapies
    Takeshi Ebara
    Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma 371 8511, Japan
    Lung Cancer 63:247-50. 2009
    ..This study aimed to assess the feasibility, efficacy and complication of hyperthermia-inclusive multimodality therapies for patient with inoperable Pancoast tumor...
  4. ncbi Expression of hypoxia-inducible factor 1? predicts clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer
    Mariko Shioya
    Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma 371 8511, Japan
    J Radiat Res 52:821-7. 2011
    ..HIF-1? expression might be predictive of recurrence-free survival and metastasis-free survival rate for rectal cancer patients treated with HCRT...
  5. ncbi Phase I study of oral S-1 plus Cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer
    Kyoichi Kaira
    Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
    Int J Radiat Oncol Biol Phys 75:109-14. 2009
    ..To determine the maximum tolerated dose (MTD) and recommended dose (RD) of S-1 in combination with cisplatin and thoracic radiotherapy in patients with unresectable Stage III non-small-cell lung cancer (NSCLC)...
  6. ncbi Usefulness of intraluminal brachytherapy combined with external beam radiation therapy for submucosal esophageal cancer: long-term follow-up results
    Hitoshi Ishikawa
    Department of Radiation Oncology, Gunma University Graduate School of Medicine, 3 39 22 Showa machi, Maebashi, Gunma 371 8511, Japan
    Int J Radiat Oncol Biol Phys 76:452-9. 2010
    ..To assess the efficacy of radiation therapy (RT) by using intraluminal brachytherapy (IBT) combined with external beam RT (EBRT) for submucosal esophageal cancer...
  7. ncbi Interaction of radiation and pemetrexed on a human malignant mesothelioma cell line in vitro
    Daisaku Yoshida
    Department of Radiation Oncology, Gunma University, Graduate School of Medicine, 3 39 22, Showa machi, Maebashi, Gunma 371 8511, Japan
    Anticancer Res 31:2847-51. 2011
    ..To investigate the interaction of the cytotoxic activity of the combination of pemetrexed and radiation in a human mesothelioma cell line...
  8. ncbi Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: the relationship between dose-volume histogram parameters and the occurrence rate
    Masahiko Okamoto
    Department of Radiation Oncology, Gunma University Graduate School of Medicine, Gunma, Japan
    Int J Radiat Oncol Biol Phys 82:e211-7. 2012
    ....
  9. ncbi The benefit of small bowel and pelvic bone sparing in excluding common iliac lymph node region from conventional radiation fields in patients with uterine cervical cancer: a dosimetric study
    Takahiro Oike
    Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
    J Radiat Res 51:715-21. 2010
    ..05). The present study suggests that modified treatment planning could be useful for selected patients for reducing small bowel complications and insufficiency fracture after radiotherapy...
  10. ncbi Primary mediastinal synovial sarcoma: a report of 2 cases
    Kyoichi Kaira
    Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Gunma, Japan
    J Comput Assist Tomogr 32:238-41. 2008
    ..They were treated with radiotherapy and chemotherapy. However, there was complete obstruction of esophagus resulting from progressive diseases. The radiographic findings and treatment were discussed...